ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-Label Tolvaptan Study in Subjects With ADPKD (TEMPO 4/4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01214421
Recruitment Status : Completed
First Posted : October 5, 2010
Last Update Posted : March 27, 2017
Sponsor:
Information provided by (Responsible Party):
Otsuka Pharmaceutical Development & Commercialization, Inc.